GlobeNewswire NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)

 What does your competent? doctor think of the research behind this?  Or is your doctor so sure they can get you 100% recovered just from their training in medical school? If so, YOU DON'T HAVE A FUNCTIONING STROKE DOCTOR, DO YOU?

I find no articles on troculeucel in Google Scholar so I have no clue where they have published research on this.

NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)

SANTA ANA, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer cell therapeutics, today announced acceptance of an oral presentation on the potential of troculeucel in patients with neurodegenerative disease and stroke, at the 16^th World Stroke Congress (“WSC 2024”) to be held in Abu Dhabi, UAE from October 23–26, 2024. Although accepted as an oral presentation, NKGen has opted to showcase troculeucel results in poster format.

E-Poster Details:

Title:	Therapeutic potential of expanded SNK01 (activated autologous natural killer cells) post-stroke to reduce neuroinflammation, inflammation-mediated cell death, and damage
Authors:	Paul Y. Song, Lucia Hui, Blanca Isaura Acosta Gallo, César Alejandro Amescua, Katia Betito, Sean Hong, Clemente Humberto Zúñiga Gil
Poster Number:	1389
Session 1:	Free Communications 09: Health Services & Implementation of Stroke Care
Date/Time/Location:	Friday, October 25, 2024, 8:00 am – 9:30 am GST; Hall F
Session 2:	Onsite and Live Streamed Session – Plenary 03: Plenary, Awards & Late Breaking
Date/Time/Location:	Friday, October 25, 2024, 10:00 am – 11:30 am GST; Hall A/Plenary

A copy of the poster will be added to the Scientific Publications page of the Company’s website at https://nkgenbiotech.com/ once the presentation has concluded.